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Hypoxemia during hemodialysis: Effects of different membranes and
dialysate compositions. Arterial oxygen tension (Pa02) and white blood
cell (WBC) count decrease during hemodialysis (HD) when certain
types of membranes are used. Two mechanisms, impaired gas exchange
due to intrapulmonary leucostasis and alveolar hypoventilation, have
been proposed. To gain more insight into their respective roles, gas
exchanges were compared in six patients with terminal renal failure
treated with HD using four different combinations: a membrane with or
without effects on WBC count and dialysaic with or without constant
Pco2. At repeated intervals Pa0 and Paco, were measured, while
expired gas volume was recorded and expired gas was sampled instan-
taneously at the mouth and measured using a mass spectrometer.
allowing the exact measurement of the alveolar-arterial oxygen gradient
(AaD02). The use of a cuprophan (CP) membrane was consistently
associated with a rapid decrease in Pa0,, WBC count and an increase in
AaDQ, irrespective of the type of dialysate used. This was not observed
when a polyacrylonitryl (PAN) membrane was used. The use of an
acetate (AT) buffered dialysate was consistently associated with a
delayed decrease in alveolar P0, respiratory quotient, and mean
inspiratory flow, irrespective of the type of dialyzer membrane used. In
HI) using a PAN membrane with constant P0 in the dialysate no drop
in WBC nor in Pa02 was observed. These results indicate that both
mechanisms of hypoxemia can he elicited with a slightly different time
sequence in the same patients and in various combinations, according
to the type of membrane and dialysate used. Patients with a compro-
mised cardiopulmonary function should preferentially be dialyzed with
a biocompatible membrane and a dialysate in which the loss of carbon
dioxide is prevented.
L'hypoxémie an cours de l'hémodialyse: Les effets de les membranes
autres et les mélanges dialysats. La pression partielle d'oxygène do sang
artériel (PaO,) et Ia leucocytose (WBC) diminuent au cours de l'hëmo-
dialyse (HD) lorsque certains types de membranes soot titilisés. Deux
méchanismes ont été proposes pour expliquer Ia baisse dc Ia FaQ2: (I)
une leucostasc intrapulmonaire provoquant Ia liberation de mCdiateurs
et affectant les Cchanges gazeux intrapulmonaires; (2) une hypoventila-
lion alvColairc sans retention de acide carboniquc, due a Ia perte de
I'acide carbonique dans Ic bain de dialyse. Afin de mieux étudier les
roles respectifs de ces deux mCchanismes six malades en insuffisance
rénale terminale ont etC traités par hemodialyse en quatre combinaisons
différentes: utilisant dune part une membrane avec ou sans effets stir Ia
leucocytose et d'autre part un dialysat maintenant ou non Ia Pco ii un
niveau constant. L'Ctude des echanges gazeux consista en Ia mesure
rCpCtée des gaz du sang landis que Ia mesure des concentrations
gazeuses de l'aire expire permettant Ia mesure exacte du gradient
alveolo-artérici en oxygène (Aa002). L'utilisation de Ia membrane
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cuprophane (CP) mais non celle de Ia membrane polyacrylonitryle
(PAN) entraIna one baisse rapide de Ia Pa02 et de Ia leucocytose ainsi
que l'augmentation du AaDO2. indépendemmant do type de dialysat
utilisC. L'utilisation do dialysat contenant de I'acetate était associC a
one baisse plus lente de Ia P02 alvéolaire. do quotient respiratoire et du
debit inspiratoire moyen. Ces effets étaient independants do type de
membrane utilisé. Ces résultats indiquent quc Ics deux mCchanismes de
l'hypoxémie peovent Ctre mis en evidence chez les mCmes patients et
dans des coinbinaisons différents d'après Ic type de membrane et Ic type
de dialysat utilisés
In 1968 Kaplow and Goffinet [1] first reported the occurrence
of a significant decrease in white blood cell (WBC) count,
mainly granulocytes, between 2 and 15 mm after the start of
hemodialysis (HD). Craddock et al [2, 3] suggested that this
leucopenia was due to intrapulmonary leucostasis resulting
from the activation of the alternative pathway of the comple-
ment system. These authors also found a decrease in FaQ2 soon
after the start of HD and an increase in the calculated alveolo-
arterial oxygen tension difference (AaDO,). It was suggested
that the parallel courses of the early leucopenia and hypoxemia
soon after the start of HD were indicative of a causal relation
between both phenomena.
Alternatively, Aurigemma et al [41 and Dumler and Levin [5]
attributed the major cause of hypoxemia to alveolar hypoventi-
lation subsequent to the loss of carbon dioxide in the dialysate.
This was supported by their finding that no hypoxernia occurred
if the decrease of Pco2 in the dialysate was prevented. These
results were only partially confirmed by Tolchin, Roberts, and
Lewis [6] since in their 'constant Pco2 dialysate set-up' they
still found a small decrease in Pa02. Recently. Dolan et al [7]
proposed once more that hypoventilation is the most important
mechanism for the hypoxemia observed with acetate dialysis.
Brautbar et al [81 showed that improved hemodynamic function
and removal of excess interstitial lung fluid during ultrafiltration
must be taken into account in the interpretalion of the hemodi-
alysis hypoxemia.
From a careful analysis of the studies mentioned above, it
seems that the divergent conclusions could be explained partial-
ly by the use of different membranes known to induce different
degrees of leucopenia [9, 101.
The purpose of this study was to unravel the respective roles
of the proposed mechanisms of FID-induced hypoxemia by
performing four different HD combinations in six patients: two
types of membranes, with and without marked effects on blood
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Table 1. Arterial oxygen tension (Pa02) during hemodialysis,
expressed in kPa
Time,
minutes 0 15 30 60 240
CP-AT
X
SD
SEM
P
12.5
1.5
0.5
10.2
1.6
0.6
<0.05
9.9
1.2
0.5
<0.05
9.2
1.3
0.5
<0.05
9.6
1.8
0.7
<0.05
CP-BC
X
SD
SEM
P
13.7
1.2
0.5
12.6
0.6
0.3
NS
11.9
1.4
0.6
<0.01
11.9
0.6
0.3
<0.05
12.6
1.1
0.5
NS
PAN-AT
X
SD
SCM
P
13.0
0.9
0.4
12.1
0.7
0.3
<0.01
11.7
0.7
0.3
<0.05
10.4
1.1
0.4
<0.05
11.0
0.8
0.3
<0.05
PAN-BC
X
SD
SCM
P
12.5
1.0
0.4
12.5
1.2
0.5
NS
12.7
1.6
0.6
NS
11.9
1.6
0.7
NS
12.1
1.2
0.5
NS
Abbreviations: CP—AT, a cuprophan membrane and acetate-contain-
ing dialysate; CP—BC, a cuprophan membrane and bicarbonate-contain-
ing dialysate; PAN—AT, a polyacrylonitryl membrane and acetate-
containing dialysate; PAN—BC, a polyacrylonitryl membrane and
bicarbonate-containing dialysate.
leucocyte count, using dialysate, with and without constant
Pco2.
Methods
Six patients, aged 32 to 71, with terminal renal failure treated
by three weekly 4-hr RD sessions were studied. Their ventila-
tory function, assessed by spirometry and body plethysmogra-
phy, was within normal limits. Informed consent was obtained.
In these patients four types of HD were compared in a
randomized order: Type 1: a cuprophan (CP) membrane (Gam-
bro LP, 1 m2, AB Gambro, Lund, Sweden) and acetate (AT)
containing dialysate; Type 2: a polyacrylonitryl (PAN) mem-
brane (Hospal, 1 m) and AT-containing dialysate; Type 3: a CP
membrane and bicarbonate (BC) containing dialysate; Type 4: a
PAN membrane and BC-containing dialysate.
The Pco2 of the BC-containing dialysate was kept constant
around 5.33 kPa, using a continuous mixing of two solutions
just before the dialysate reached the artificial kidney.1
Vascular access in all patients consisted of an arteriovenous
Cimino Brescia fistula. Heparin was used to maintain antico-
agulation. Blood flow was maintained at 250 ml/min, and blood
pressure was monitored every 5 mm with a Dynamap (Applied
Medical Research Corporation, Tampa, Florida). In the rare
cases of hypotension the experiment was not continued. Dialy-
ISolutjon I: Na 80 mEq/titer, Ca 3.5 mEq/liter, K 1 mEq/liter,
Mg 1 mEq/liter, HC03 0 mEq/liter, CI 85.5 mEq/liter, Ac 4
mEq/liter.
Solution 2: Na 59 mEq/liter, HC03 39 mEq/liter, Cl— 20 mEq/liter.
sis was performed with an open single pass system and con-
trolled ultrafiltration (1.5 to 2.5 liter/4 hr of HD) using a double-
headed pump system [11].
Blood samples were drawn and analyzed for blood gas
tension (Corning 175 Automatic) and WBC count (Coulter
Counter). Blood samples for blood gas measurements were
drawn into heparinized cooled (4°C) glass syringes and immedi-
ately assayed for pH, arterial carbon dioxide tension (PaCO2),
HC03, base excess, and oxygen saturation. The analysis was
performed immediately, obviating the need for correction of the
time delay between sampling and analysis. Blood for WBC
count was collected in tubes containing EDTA. The patients,
comfortably seated in arm chairs, were breathing room air
through a two-way 'J' Collins valve. Their expired gas was
collected through a pneumotachygraph (Jaeger) into a gas-
mixing chamber. Expired gas volume was obtained by integra-
tion of the flow signal from the pneumotachygraph and record-
ed on a 4-channel oscilligraphic recorder (Honeywell). Using a
mass spectrometer (Centronic 200 MGA), calibrated with air,
and a gas mixture containing 15% 02 and 5.5% CO2. gas was
either continuously sampled at the mouth or from the gas-
mixing chamber and analyzed for oxygen and carbon dioxide
concentrations. From recorded gas volumes and mixed expired
gas concentrations of oxygen and carbon dioxide, oxygen
uptake (V02) and carbon dioxide output (VCO2) were calculat-
ed as well as respiratory quotient (RQ), minute ventilation
(VE), tidal volume (VT), inspiratory time (Ti), and the ratio of
tidal volume to inspiratory time (VT/Ti). This ratio which
represents mean inspiratory flow has been introduced recently
as a useful index of respiratory drive [12, 131.
Alveolar oxygen tension (PAO2) and alveolar carbon dioxide
tension (PACO2) were assumed to be equal to end-tidal oxygen
and carbon dioxide tension obtained from continuous sampling
of expired air at the mouth. The alveolar-arterial tension
difference (AaDO2) was calculated as the difference from end-
tidal to arterial P02 (Pa02), measured simultaneously. Follow-
ing an adaptation period of at least 3 mm, all these parameters
were obtained at 0, 15, 30, 60, 120, 180 and 240 mm after the
start of HD.
Statistics. The overall changes occurring after the start of HD
were evaluated using analysis of variance. Differences from
control values at time 0 and differences between values at a
given time were evaluated using Student t test for paired
observations. The degree of significance was set at the 0.05
level.
Results
Pa02 decreased significantly in all types of HD (Fig. 1, Table
1) except in the type using a PAN membrane with BC in the
dialysate. CP-HD induced a rapid decrease in Pa02 whereas in
HD, using PAN and AT, the decrease was more delayed. White
cell count (Fig. 2) rapidly decreased to 30% of control in the
first 15 mm of HD using CP but remained constant while using a
PAN membrane. At the end of a 4-hr session WBC count was
again within normal limits. End-tidal oxygen tension (PAO2)
(Fig. 3, Table 2) decreased significantly in acetate HD, indepen-
dently of the type of the membrane used, during the first hour
and subsequently remained constant, indicating sustained
hypoventilation.
Mean inspiratory flow (VT/Ti) (Fig. 4), taken as an index of
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Abbreviations are the same as for Table I.
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Fig. 1. Pa02 with a significant decrease in three out of four tvpe.s of
hemodialysis, most markedly in the cuprophan membrane and acetate-
containing dioly3ote (CP-AT) dialy3i.s. With cuprophan membrane and
bicarbonate-containing dialysate (CP BC) dialysis a tendency toward
normalization is observed at 240 mm. In both AC dialysis procedures
FaQ2 remains significantly below the initial level. Symbols are: ', P <
0.05; , P <0.01, both P values are versus time 0: x—x, CP-AT (100%
= 12.53 kPa); O---O, PAN-AT(l00% — 13.03 kPa); A---A. CP-BC (100%
— 13.65 kPa); •---•, PAN-BC (l00/ 12.47 kPa). PAN represents a
polyacrylonitryl membrane. (Mean SEM, N = 6)
neuromuscular drive, decreased during HD with AT but re-
mained constant with bicarbonate (BC). Whereas V02 re-
mained constant, VCO2 displayed mild decreases in set-ups
with AT-containing dialysate. This is more strikingly reflected
by changes in RQ (Fig. 5): A significant and continuous
decrease to less than 0.60 with AT, and the mean RQ not
decreasing below 0.75 with BC, indicated that the loss of carbon
dioxide was partially prevented. Arterial Pco2 remained nearly
constant in all groups but was slightly higher in the BC group
Fig. 2. White cell count unaltered in both PAN dial)'ses. An early drop
in the white cell count is observed with both CP dialyses. Symbols are:
, P <0.05; , P <0.01; both P values are versus time 0; x---x, CP-AT;
0-—C, PAN-AT; A---A, CF-BC; •---•, PAN-BC. Meanings of the
abbreviations are in the legend to Figure 1. (Mean SEM, N — 6)
(Fig. 6). A similar increase in pH was observed in all groups.
Obviously HCO3 levels were higher in the BC dialyzed group.
The changes in Pa02 and PAO2 are reflected by the directly
measured alveolo-arterial oxygen tension difference (AaDO2)
that was almost unchanged in HD with PAN, but significantly
increased in HD with CP membrane (Fig. 7).
Discussion
From these results it is clear that the effect upon arterial P02,
leucocyte count, and alveolo-arterial oxygen gradient within
minutes after the start of HD is markedly different for the two
types of membranes used. Independently of the type of the
membrane (CP or PAN) used, however, dialysate-containing
AT always induces a delayed, but as striking, decrease in
15
Table 2. Alveolar oxygen tension (PAO2) during hemodialysis, expressed in kPa
30 60 120Time, minutes
CP-AT
X
SD
SEM
P
0
14.9
0.6
0.3
13.8
0.7
0.3
0.01
13.7
1.0
0.4
0.01
180 240
14.3
0.6
0.3
0.01
13.6
0.6
0.3
0.01
14.0
0.6
0.3
0.05
13.6
0.6
0.3
0.01
CF-BC
X
SD
SEM
P
16.3
0.4
0.2
16.1
1.0
0.5
NS
16.1
0.5
0.3
NS
15.9
0.6
0.3
NS
15.9
0.5
0.2
NS
15.8
0.5
0.3
NS
15.7
0.3
0.2
0.01
PAN-AT
X
SD
SEM
P
15.4
1.0
0.4
14.5
0.7
0.3
NS
13.9
0.8
0.4
0.01
13.5
0.7
0.3
0.01
14.0
0.6
0.3
0.01
14.0
0.7
0.3
0.01
13.4
1.2
0.6
0.01
PAN-BC
X
St)
SFM
p
15.4
0.8
0.3
15.5
0.8
0.3
NS
15.5
1.0
0.4
NS
15.4
0.9
0.4
NS
15.1
1.1
0.4
NS
15.2
1.1
0.4
NS
15.0
1.2
0.5
NS
100
S
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C
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C
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Fig. 4. Mean inspiratory flow (VT/Ti), used as an index of neuromuscu-
lar drive, with a significant decrease in hemodialysis using acetate-
containing dialysate, but constant when bicarbonate-containing dialy-
sate is used. Symbols are: . P < 0.05; ', P < 0.01; both P values are
versus time 0; LI, CP-AT; , PAN-AT;U, CP-BC; LI, PAN-BC. (Mean
SEM, N = 6)
alveolar P02, respiratory quotient, and mean inspiratory flow.
These differences were observed in the six patients studied in
the same hemodialysis unit and submitted to the four types of
HD performed in a randomized order. Changes occurring
during HD can only be validly compared if control values at the
start of HD were also comparable. There was no statistical
difference in all the parameters studied. Only for arterial P02
did differences approximate 10%. However, end-tidal P02
values were similarly shifted resulting in nearly identical start-
ing values for AaDO2.
Our main purpose in measuring alveolar P02 and alveolo-
arterial oxygen gradient was to differentiate changes affecting
intrapulmonary gas exchange, (increasing AaDO2) from those
causing alveolar hypoventilation (thus decreasing alveolar
P02). The use of a direct measurement of end-tidal P02 as an
index of alveolar P02 could be criticized since fluctuations are
known to occur during the ventilatory cycle [14]. First, howev-
er, values used were the mean of at least ten respiratory cycles;
second, changes in our patients were small; third, an end-tidal
(alveolar) plateau could be well identified on their instantaneous
curves; and fourth, calculation of alveolar P02 using the Bohr
equation including the actual (and not an assumed) RQ value
yielded similar results. Hence, we estimate that our measure-
ments of PAO2 and AaDO2 allowed us to separate validly both
mechanisms of hypoxemia.
Most of the previous studies [2—6] have claimed that their
proposed mechanism was solely responsible for the observed
changes in blood gases. Only Hakim and Lowrie [15] showed
statistical basic differences in Pa02 between different mem-
branes and different compositions of the dialysate.
Our results indicate that both altered intrapulmonary gas
exchange and alveolar hypoventilation determine the degree of
hypoxemia, according to the type of membrane used and the
composition of the dialysate, respectively.
The use of a cuprophan membrane is consistently associated
with the rapid occurrence of altered intrapulmonary gas ex-
change and a marked leucopenia. The different effects on WBC
suggest a better biocompatibility of the PAN membrane, and it
is quite tempting to speculate that the intrapulmonary changes
are related to leucopenia. This is strongly supported by histo-
logical studies in animals and evidence of complement activa-
tion in humans, but the causal relation between both phenome-
na in humans remains to be determined [2, 3].
The 15-mm time lag observed between maximum decrease in
WBC and maximum decrease in Pa02 with the use of CP
membrane does not rule out this causal relation. This could be
the time needed by the mediators or oxygen radicals released
during leucocyte aggregation for alteration of pulmonary vascu-
lar permeability resulting in changes of oxygen transfer through
the lung [16].
The use of AT instead of BC in the dialysate was consistently
associated with alveolar hypoventilation and hypoxemia. The
latter could result from a direct effect of acetate by some, as yet
=
C
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Time, rn/n
Fig. 3. PAO2 constant in both hemodialysis procedures using bicarbon-
ate dialysate. The significant decrease in PAO2 observed at 30 mm with
AT in the dialysate remains constant during the whole observation
period. Symbols are the same as found in Figures 1 and 2. (Mean
SEM, N = 6)
I I I
0 60 120 180 240
Time, rn/n
Fig. 5. Respiratory quotient (RQ = TCO2PTO2) with a sign(ficant
decrease in hemodialysis using acetate, but within normal limit in
hemodialysis using bicarbonate. The symbols are the same as those
used in Figure 1. (Mean SEM, N = 6)
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Fig. 6. Arterial carbon dioxide tension near/v
constant during hemodialvsis, but slight/v
higher in the bicarbonate group. pH increases
similarly in all groups. Plasma HCO levels
are higher in the hemodialysis using
bicarbonate in the dialysate. The symbols are
the same as those used in Figure 1. (Mean
SEM, N = 6)
The severest mean decrease in P02 in our study amounted to
25% of initial value which is critical in patients with compro-
mised cardiopulmonary function. The clinical implications of
our results clearly is that these patients should preferentially be
dialyzed with a biocompatible membrane (for example, PAN)
and a dialysate in which loss of carbon dioxide is prevented.
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Fig. 7. The alveolo-arterial oxygen tension dijfrrence (AaDO,) with
significant increase in hemodia/vsis using a cuprophan membrane.
With polyacrylonitryl no significant increase is observed. The symbols
used are the same as those used in Figure 4. (Mean SEM, N = 6)
unclear, mechanism [17, 18]. It seems more likely that the loss
of carbon dioxide through the dialysate, with Pco in the blood
returning to the patient decreasing to as low as 2 kPa, causes
alveolar hypoventilation and hypoxemia. This hypoventilation
unaccompanied by carbon dioxide retention in the arterial
blood, as already stressed by others [191, results from a
decreased respiratory drive as indicated by the significant
decrease in VT/Ti [13].
Phillipson, Duffin, and Cooper [20] have recently demonstrat-
ed the critical dependence of respiratory drive and rhythmicity
on the metabolic carbon dioxide load by causing complete
cessation of breathing at normal arterial blood gases in adult
sheep, when carbon dioxide was removed from the blood at a
rate equal to its metabolic production. In our patients we also
found the hypoventilation to occur slowly and not correlated
with changes in arterial Pco2. The suggestion that it could be
mediated through slowly adapting chemoreceptors in the ve-
nous circulation or in the lungs remains to be proven. Recently,
more experimental evidence has been presented for the pres-
ence in dogs of carbon dioxide sensitive pulmonary chemore-
ceptors controlling minute ventilation [21].
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